Fri.Aug 16, 2019

Amazon Maisel Day Goes Wrong In Santa Monica

socalTECH

A promotion by Amazon went awry in Santa Monica on Thursday, after the Santa Monica Police had to shut down a promotion at a local Chevron for causing major traffic woes. As part of the promotion, Amazon had offered up 1959 pricing on gasoline (30 cents a gallon) to Amazon Prime members. The promotion had included deals that featured 1959 prices for food, movie tickets, hotel tickets, and other purchases to promote the original Amazon Prime series "The Marvelous Mrs. Maisel".

8 Keys To Delivering Exceptional Customer Experiences

Startup Professionals Musings

Most businesses spend big money testing their brand logo, catchy marketing phrases, and demographics, but spend little time training and validating that their employees can and do deliver exceptional experiences to their customers.

Adesso Expands Line Of KODAK Peripherals

socalTECH

Walnut, California-based Adesso , which manufactures computer peripherals, says it is rolling out a line of products with the KODAK brand on it, including new education and office peripherals for the PC and Mac platforms.

Walnut 109

Will Porsche Fans Ever Live in a Driverless World? Porsche Says No.

Xconomy

Imagine the transportation future 20 years from now. Here’s one way things could roll on a weekday: Many of us get picked up at home by a sturdy, standardized, driverless car that will also scoop up a few of our neighbors who work at other businesses near ours.

Within Rolls Out New Augmented Reality Story

socalTECH

Los Angeles-based Within , a venture-backed startup which is developing augmented reality software, said this week that it has relased another, augmented reality title on its app, Wonderscope.

Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More

Xconomy

We learned last week that the FDA was investigating Novartis for manipulating animal data related to its $2 million-a-dose gene therapy Zolgensma. The activity took place at AveXis, the firm Novartis bought for $8.7 billion in 2018, and Novartis reportedly knew but failed to report it to the FDA before the agency approved Zolgensma in May. There are still many unanswered questions, such as when the data-cooking took place. Before Novartis bought AveXis? After?